65 related articles for article (PubMed ID: 6440503)
21. Assessment of left ventricular function from the mitral valve echocardiogram following positive and negative inotropic interventions.
Bambach T; Nechwatal W; Sigel H; Stauch M
Z Kardiol; 1983 Nov; 72(11):642-8. PubMed ID: 6659641
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular effects of the positive inotropic agents pimobendan and sulmazole in vivo.
von Meel JC
Arzneimittelforschung; 1985; 35(1A):284-8. PubMed ID: 4039168
[TBL] [Abstract][Full Text] [Related]
23. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
[TBL] [Abstract][Full Text] [Related]
24. [The effect of AR-L 115 BS on contractility dynamics of the isolated, metabolically supported dog heart (author's transl)].
Hockerts T; Höcht B; Broll R; Trenkel K; Sieber J; Kilian A; Brendle B
Arzneimittelforschung; 1981; 31(1a):157-61. PubMed ID: 7195211
[TBL] [Abstract][Full Text] [Related]
25. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
Travill CM; Pugh S; Noble MI
Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
[TBL] [Abstract][Full Text] [Related]
26. Effects of AR-L 115 BS, a new cardiotonic compound, on cardiac contractility, heart rate and blood pressure in anaesthetized and conscious animals.
Diederen W; Kadatz R
Arzneimittelforschung; 1981; 31(1a):146-50. PubMed ID: 7195208
[TBL] [Abstract][Full Text] [Related]
27. Ergometric and hemodynamic studies on a new cardiotonic agent AR-L 115 BS.
Pozenel H
Arzneimittelforschung; 1981; 31(1a):263-6. PubMed ID: 7195238
[TBL] [Abstract][Full Text] [Related]
28. Action of AR-L 115 BS on myocardial oxygen consumption, cardiac performance and vascular resistance and capacitance.
Dämmgen J; Kadatz R; Diederen W
Arzneimittelforschung; 1981; 31(1a):151-4. PubMed ID: 7195209
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the positive-inotropic activity of the benzimidazole derivative AR-L 115 BS in isolated guinea pig atria.
Dahmen M; Greeff K
Arzneimittelforschung; 1981; 31(1a):161-5. PubMed ID: 7195212
[TBL] [Abstract][Full Text] [Related]
30. First clinical trial with etomoxir in patients with chronic congestive heart failure.
Schmidt-Schweda S; Holubarsch C
Clin Sci (Lond); 2000 Jul; 99(1):27-35. PubMed ID: 10887055
[TBL] [Abstract][Full Text] [Related]
31. Hemodynamic effects of the new inotropic agent sulmazol (AR-L115 BS) administered intravenously to patients with severe heart failure.
Hagemeijer F; van Mechelen R; Schelling A
Herz; 1983 Feb; 8(1):41-6. PubMed ID: 6832692
[No Abstract] [Full Text] [Related]
32. Effects of AR-L 115 BS on hemodynamics, myocardial oxygen consumption and cardiac pumping efficiency.
Hellige G; Baller D; Ensink FB; Zipfel J; Wolpers HG; Bretschneider HJ
Arzneimittelforschung; 1981; 31(1a):155-6. PubMed ID: 7195210
[TBL] [Abstract][Full Text] [Related]
33. Aortic peak flow velocity as an index of myocardial contractility in the conscious rat.
Dowell RT; Houdi AA
Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):533-9. PubMed ID: 9442476
[TBL] [Abstract][Full Text] [Related]
34. Activating effects of AR-L 115 BS on the Ca2+ sensitive force, stiffness and unloaded shortening velocity (Vmax) in isolated contractile structures from mammalian heart muscle.
Herzig JW; Feile K; Rüegg JC
Arzneimittelforschung; 1981; 31(1a):188-91. PubMed ID: 7195218
[TBL] [Abstract][Full Text] [Related]
35. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
[TBL] [Abstract][Full Text] [Related]
36. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular effects of AR-L115 BS in conscious dogs with and without chronic congestive heart failure.
Pouleur H; Rousseau MF; van Mechelen H; Roncoroni L; Ries A; Charlier AA
J Cardiovasc Pharmacol; 1982; 4(3):409-18. PubMed ID: 6177937
[TBL] [Abstract][Full Text] [Related]
38. Hemodynamic properties of a new-generation positive luso-inotropic agent for the acute treatment of advanced heart failure.
Sabbah HN; Imai M; Cowart D; Amato A; Carminati P; Gheorghiade M
Am J Cardiol; 2007 Jan; 99(2A):41A-46A. PubMed ID: 17239704
[TBL] [Abstract][Full Text] [Related]
39. [Animal studies on the tolerability of AR-L 115 BS (author's transl)].
Schneider P; Bauer M; Eckenfels A; Lehmann H; Lützen L; Ueberberg H
Arzneimittelforschung; 1981; 31(1a):226-32. PubMed ID: 7195227
[TBL] [Abstract][Full Text] [Related]
40. [Hemodynamic and coronary effects of intravenous verapamil in coronary insufficiency].
Zygelman M; Mérillon JP; Guiomard A; Eustigneff T; Zannier D; Gourgon R
Arch Mal Coeur Vaiss; 1981 Jun; 74(6):685-94. PubMed ID: 6794490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
